Stockscreener 앱 받기
12.68
2.08%
-0.27
시간 외 거래:
12.68
전일 마감가:
$12.95
열려 있는:
$12.99
하루 거래량:
568.04K
Relative Volume:
0.67
시가총액:
$1.33B
수익:
-
순이익/손실:
$-115.88M
주가수익비율:
-8.1976
EPS:
-1.5468
순현금흐름:
$-104.72M
1주 성능:
-11.39%
1개월 성능:
-2.61%
6개월 성능:
-51.92%
1년 성능:
-21.68%
1일 변동 폭
$12.46
$13.18
1주일 범위
$12.46
$14.50
52주 변동 폭
$10.60
$38.12
엣지와이즈 Stock (EWTX) Company Profile
명칭
Edgewise Therapeutics Inc
전화
720-262-7002
주소
1715 38TH ST, BOULDER
EWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
12.68 | 1.42B | 0 | -115.88M | -104.72M | -1.5468 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
엣지와이즈 Stock (EWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 개시 | Raymond James | Strong Buy |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-04-30 | 개시 | Guggenheim | Buy |
| 2025-04-02 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-01-22 | 개시 | Stifel | Hold |
| 2024-11-22 | 개시 | Evercore ISI | Outperform |
| 2024-03-07 | 개시 | Piper Sandler | Overweight |
| 2023-05-01 | 개시 | Truist | Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2022-01-28 | 개시 | Goldman | Neutral |
모두보기
엣지와이즈 주식(EWTX)의 최신 뉴스
What makes Edgewise Therapeutics Inc. stock price move sharplyFree Portfolio Diversification Stock Ideas - Newser
Edgewise Therapeutics (NASDAQ:EWTX) Given New $49.00 Price Target at Royal Bank Of Canada - MarketBeat
Is Edgewise Therapeutics Inc. stock poised for growthFree AI Based High Gain Watchlist Scanner - Newser
Real time scanner hits for Edgewise Therapeutics Inc. explainedQuick Profit Setup with Signal Forecast - Newser
Edgewise Therapeutics Inc. stock trendline breakdownFree Triple Digit Growth Focused Trade Plan - Newser
How Edgewise Therapeutics Inc. stock performs during market volatilityFree Fast Gaining Stock Screener Report - Newser
Edgewise Therapeutics (EWTX) to Release Quarterly Earnings on Thursday - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - FinancialContent
Quantitative breakdown of Edgewise Therapeutics Inc. recent moveMomentum Trading Guide with Safety Limits - Newser
What candlestick patterns are forming on Edgewise Therapeutics Inc.Free Day Trading Signals With High Precision - Newser
TD Asset Management Inc Makes New $730,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Is Edgewise Therapeutics Inc. stock entering bullish territoryShort Term Opportunity Finder with Tools - Newser
How sentiment analysis helps forecast Edgewise Therapeutics Inc.Free Reliable Investment Entry Point Signals - Newser
How Interest Rate Changes Impact Edgewise Therapeutics Inc. Stock PerformanceWeekly Hot Stocks Based on Volume Flow - Newser
Edgewise Therapeutics stock price target raised to $49 at RBC Capital - Investing.com Canada
RBC Lifts Price Target on Edgewise Therapeutics to $49 From $48, Keeps Outperform, Speculative Risk - MarketScreener
We're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Rate - uk.finance.yahoo.com
Edgewise Therapeutics Advances in Muscular Dystrophy Trials - TipRanks
Edgewise Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock with $46 price target - Investing.com Canada
Edgewise Therapeutics: Strong Financial Health and Promising Clinical Advances Drive Buy Rating - TipRanks
Edgewise Therapeutics' Accelerating Clinical Pipeline: A Catalyst for Valuation Re-rating in 2025? - AInvest
Edgewise Therapeutics shares surge as Q2 loss narrows, beats estimates By Investing.com - Investing.com South Africa
Edgewise Therapeutics shares surge as Q2 loss narrows, beats estimates - Investing.com
Edgewise Therapeutics: Pioneering Muscle Disease Innovation with Strong Q2 Results and Promising Late-Stage Pipeline - AInvest
Edgewise Therapeutics, Inc. SEC 10-Q Report - TradingView
Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Edgewise Therapeutics Soars 5.44% on Inducement Grants - AInvest
Applying Wyckoff theory to Edgewise Therapeutics Inc. stockLow Risk Trade Timing with Analysis Metrics - Newser
Edgewise Therapeutics (EWTX) to Release Earnings on Thursday - Defense World
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - MarketScreener
Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.9%Here's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Edgewise Therapeutics, Inc. (EWTX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Edgewise EWTX 2025Q2 Earnings Preview Upside Potential Amid Clinical Trial Progress - AInvest
Pomerantz LLP investigates Edgewise Therapeutics over potential securities fraud claims. - AInvest
Visualizing Edgewise Therapeutics Inc. stock with heatmapsDaily Breakout List with Smart Filters - Newser
Can Edgewise Therapeutics Inc. Bounce Back From Weekly LowReversal Alert Based on RSI Indicator Confirmed - metal.it
What is the risk reward ratio of investing in Edgewise Therapeutics Inc. stockGet timely alerts on top-performing stocks - Jammu Links News
What analysts say about Edgewise Therapeutics Inc. stockInvest confidently with real-time market updates - Jammu Links News
Is Edgewise Therapeutics Inc. stock overvalued or undervaluedFree Consultation - Jammu Links News
Edgewise Therapeutics (NASDAQ:EWTX) Trading 8.3% HigherHere's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Edgewise Therapeutics, Inc. (EWTX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
What drives Edgewise Therapeutics Inc. stock priceBuild wealth steadily with expert advice - Jammu Links News
Does Edgewise Therapeutics Inc. stock perform well during market downturnsUnlock your portfolio’s full growth potential - Jammu Links News
What catalysts could drive Edgewise Therapeutics Inc. stock higher in 2025Unlock exclusive trading tools and resources - Jammu Links News
Does Edgewise Therapeutics Inc. qualify in momentum factor screeningHigh Probability Trade Outcome Prediction - Newser
Edgewise Therapeutics (NASDAQ:EWTX) Coverage Initiated by Analysts at Raymond James Financial - MarketBeat
엣지와이즈 (EWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):